| Company/Division name | HPNE |
| Parent company | HPNE |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| State(s) reshored to: | RI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | Bioprocess |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Biomedical Advanced Research and Development Autho |
| Government Incentive dollar amount: | $15 million |
